Back to Authors

Hauptschein, Robert

Mayo Clinic

JW Theriac Pharmaceutical, Bothell, WA

Citations 1

Phase 1 study of CWP232291 in relapsed/refractory acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
Faderl, Stefan, Pagel, John M. , Yoon, Sung‐Soo, Pardanani, Animesh , Hauptschein, Robert, Lee, Kyoung-June, Cortes, Jörge E. , Jung, Chul Won , Yoon, Sung‐Soo , Koh, Youngil , Lee, Je‐Hwan

Journal of Clinical Oncology | April 19, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 7044-7044

10.1200/jco.2015.33.15_suppl.7044 Get It